ClinicalTrials.Veeva

Menu

Registry Study on Drug Therapy and Clinical Outcomes in Patients With Acute Coronary Syndrome

Capital Medical University logo

Capital Medical University

Status

Not yet enrolling

Conditions

Drug Therapy
Acute Coronary Syndrome

Study type

Observational

Funder types

Other

Identifiers

NCT04184583
ANZHEN HOSPITOL-LY-02

Details and patient eligibility

About

Registry Study on Drug Therapy and Clinical Outcomes in Patients With Acute Coronary Syndrome

Enrollment

10,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Informed consent has been signed.
  • Patients diagnosed in our hospital with acute coronary syndrome.
  • Age ≥18.
  • Life expectancy ≥12 months.

Exclusion criteria

  • Severe lack of important information such as history of previous medication, history of previous disease, history of surgery.
  • Pregnant and lactating women.
  • Mental disorders, or inability to communicate effectively with researchers, or failure to comply with research protocols.

Trial contacts and locations

1

Loading...

Central trial contact

Yi Zhang, PhD; Yang Lin, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems